Press release
Liposome Drug Delivery Market Set to Transform Targeted Therapy: Explosive Growth, Innovation, and Investment Opportunities 2025-2032 | Major players - Celsion Corporation, ASTELLAS PHARMA, INC., Gilead Sciences, Inc.
Liposome Drug Delivery Market
The Global Liposome Drug Delivery Market is estimated to reach at a CAGR of 7% during the forecast period 2024-2031.
The Liposome Drug Delivery Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/liposome-drug-delivery-market?sz
The Liposome Drug Delivery Market encompasses technologies, products, and services that use lipid bilayer vesicles to encapsulate and transport therapeutic agents, improving solubility, stability, targeting, and controlled release. It serves pharmaceuticals and biotechnology sectors across oncology, infectious diseases, vaccines, and gene therapy, driven by rising R&D, personalized medicine, and demand for safer, more effective treatments worldwide in clinical use today.
Recent Key Developments of United States:
✅ December 2025: Partnership announcements emerged between pharma leaders and startups for next-gen liposomal vaccines, driven by precision medicine demands.
✅ November 2025: Clinical trial expansions occurred for liposome-based antiviral delivery systems, focusing on improved bioavailability in respiratory treatments.
✅ October 2025: Regulatory progress advanced with FDA fast-track designation for a novel liposomal oncology formulation by a major biotech firm, enhancing targeted cancer therapies.
Recent Key Developments of Japan:
✅ December 2025: Industry collaborations advanced PEG-stabilized liposomes for metabolic treatments, boosting hospital adoption rates.
✅ November 2025: R&D investments rose in liposomal CNS disorder therapies, aligning with Society 5.0 initiatives for advanced drug delivery.
✅ October 2025: PMDA approved a liposome-encapsulated antifungal drug variant, supporting Japan's precision oncology push amid aging demographics.
List of the Key Players in the Liposome Drug Delivery Market:
Celsion Corporation
Spectrum Pharmaceuticals, Inc.
ASTELLAS PHARMA, INC.
Gilead Sciences, Inc.
Ipsen Pharma
Pacira BioSciences, Inc.
Luye Pharma Group
Janssen Pharmaceuticals
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Taiwan Liposome Company, Ltd.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/liposome-drug-delivery-market?sz
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Segments Covered in the Liposome Drug Delivery Market:
By Product: Liposomal doxorubicin, Liposomal paclitaxel, Liposomal amphotericin B, Other.
By Technology: Stealth liposome technology, Non-PEGylated liposome technology, DepoFoam liposome technology.
By Application: Cancer Therapy, Viral vaccines, Pain management, Others.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=liposome-drug-delivery-market
Chapter Outline
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Liposome Drug Delivery market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Liposome Drug Delivery Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The Global Liposome Drug Delivery market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Liposome Drug Delivery Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the Liposome Drug Delivery Market in 2025?
◆ What is the projected growth rate of the Liposome Drug Delivery Market through 2033?
◆ Who are the key players in the Liposome Drug Delivery Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liposome Drug Delivery Market Set to Transform Targeted Therapy: Explosive Growth, Innovation, and Investment Opportunities 2025-2032 | Major players - Celsion Corporation, ASTELLAS PHARMA, INC., Gilead Sciences, Inc. here
News-ID: 4345958 • Views: …
More Releases from DataM Intelligence 4Market Research
Oilfield Stimulation Chemical Market is expected to reach US$ 9.72 billion by 20 …
Market Size and Growth:
The Oilfield Stimulation Chemical Market size reached US$ 4.30 billion in 2024 and is expected to reach US$ 9.72 billion by 2032, growing at a CAGR of 10.6% during the forecast period 2025-2032.
The Oilfield Stimulation Chemical Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make…
Laser Hair Loss Treatment Market Set for Rapid Growth as Demand for Non-Invasive …
Market Overview:
The Laser Hair Loss Treatment Market is predicted to reach at a CAGR of 12.0% during the forecast period (2024-2031).
The Laser Hair Loss Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and…
Macular Degeneration Treatment Market is expected to reach US$ 15.7 billion by 2 …
Market Size and Growth:
The Macular Degeneration Treatment Market size reached US$ 9.8 billion in 2024 and is expected to reach US$ 15.7 billion by 2033, growing at a CAGR of 5.26% during the forecast period 2025-2033.
The Macular Degeneration Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make…
Nitrogenous Fertilizer Market is expected to reach US$ 102.41 billion by 2033 | …
Market Size and Growth:
The Nitrogenous Fertilizer Market size reached US$ 173.67 billion in 2024 and is expected to reach US$ 102.41 billion by 2033, growing at a CAGR of 3.63% during the forecast period 2025-2033.
The Nitrogenous Fertilizer Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions…
More Releases for Liposome
Liposome Manufacturing Market to Hit USD 21.8 Billion by 2034
Liposomes are spherical vesicles composed of phospholipid bilayers that encapsulate therapeutic molecules, providing enhanced drug delivery, controlled release, and reduced toxicity. Liposomes are widely used in oncology, vaccines, gene therapy, and dermatology, offering improved bioavailability and targeted delivery for both small molecules and biologics.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72611
The global liposome manufacturing market is expanding due to the growing demand for advanced drug delivery systems, increasing…
Irinotecan Hydrochloride Liposome Injection Market Forecast to 2034
Market Overview
As of 2024, the Irinotecan Hydrochloride Liposome Injection Market is valued at USD 116 million. It is expected to grow at a Compound Annual Growth Rate (CAGR) of 10.1% from 2024 to 2034, reaching approximately USD 305 million by 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/59123
Key Market Highlights:
• Base Year: 2023
• Forecast Period: 2024-2034
• 2024 Market Size: USD 116 Million
• 2034 Forecasted Size: USD 305 Million
• CAGR: 10.1%
• Primary Driver: Rising prevalence of…
Doxorubicin Hydrochloride Liposome Injection Market Size, Share and Growth Repor …
" The global market for Doxorubicin Hydrochloride Liposome Injection is projected to reach approximately $1.2 billion in 2024. The forecast period from 2025 to 2034 is expected to witness significant expansion, with a projected market value increasing to around $2.5 billion by 2034. This growth represents a Compound Annual Growth Rate (CAGR) of approximately 8.1% during the forecast period, driven by rising incidences of various cancers, advancements in liposomal drug…
Liposome Drug Delivery Market Future Prediction Report By 2031
A new market study report by The Insight Partners on the Liposome Drug Delivery Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period.
Get PDF Sample Report…
Liposome Makeover: How Creative Biolabs is Amping Up Drug Delivery
Creative Biolabs is at the forefront of the liposome "revolution", offering cutting-edge liposome development services tailored to meet the complex needs of researchers and pharmaceutical companies.
New York, USA - September 11, 2024 - As the biotech and pharmaceutical sectors continue their rapid evolution, the demand for innovative and efficient drug delivery systems has reached an all-time high. One of the most promising developments in this field has been the use…
Liposome in Cosmetics Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Liposome in Cosmetics market.
Liposomes are spherical vesicles in which their central aqueous section is surrounded by one or more of a bilayer membrane (Lamella) that is frequently enclosed by aquatic environments. These vesicles are formed when amphiphilic lipids confront with aqueous milieu. They can vary in size from 15 nm to several microns. In the…
